Case File
efta-efta01135546DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01135546
Pages
4
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: "McGraw, Thomas"
Subject: Fwd: Fw: Fw: FW: Early Termination Calculation
Date: Wed, 29 May 2013 20:32:01 +0000
Attachments: Attachments.zip
Inline-Images: ATT00002.gif; ATT00001.gif
Forwarded message
From: Fenn, Patrick 4
Date: Mon, May 27, 2013 at 8:56 AM
Subject: Fw: Fw: FW: Early Termination Calculation
To: "[email protected]" [email protected]>
Thought I had forwarded this last week. Apologies. I'll put some thoughts down re candidate solutions. Let me do that
while I'm in Europe and we can speak later in the week. That ok?
From:
[mailto:
Sent: Monday, May 20, 2013 08:26 PM
To: Fenn, Patrick
Cc:
Subject: Re: Fw: FW: Early Termination Calculation
Hi Patrick.
Attached are models at the requested $30 and S35 per share value. Thanks,
Brian
asir
HUH'Iff E
_RNST&YOUNG
From:
To:
Dale:
Subject:
"Fenn. Patrick"
Brian Knudson I Partner I National Tax - Partnership and Joint Ventures
Ernst & Young LLP
Office:
Thank you for considering the environmental impact of printing emails.
05/20201302:17 PM
Fw: FW: Early Termination Calculation
EFTA01135546
Hi Brian. Additional requests from Epstein. Rest -- you can ignore for now -- is about the Tufts gain stuff that
he's now focused on. Thanks
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Monday, May 20, 2013 08:19 AM
To: Fenn, Patrick
Subject: Re: FW: Early Termination Calculation
could they run the calcuations at a 30 and 35 dollar price for apo , thanks, also have you given tought to
refreshing the basis in amh.? new loan,? partnership, guaranteed either payments or assignment of tra in
whole?
On Mon, May 20, 2013 at 7:46 AM, Fenn, Patrick 4
> wrote:
Jeffrey,
Calculation from Brian Knudson at E&Y. Note that this relates only to the unexchanged units, and does not
include the existing TRA payments.
Regards
Hi Patrick,
Attached is the calculation that we put together for Leon. As we discussed, this only calculates the
estimated early termination payment with respect to the APP units held by Leon - it does not yet
calculate the estimated early termination payment with respect to remaining TRA benefits related to
the 2007 exchange. I have added an assumptions tab to the workbook outlining many of the items that
we discussed. Thanks,
Brian
III LIE_RNST&YoUNG
Brian Knudson I Partner I National Tax - Partnership and Joint Ventures
Ernst & Young LLP
Thank you for considering the environmental impact of printing entails.
EFTA01135547
Any U.S. tax advice contained in the body of this e-mail was not intended or written to be used,
and cannot be used, by the recipient for the purpose of avoiding penalties that may be imposed
under the Internal Revenue Code or applicable state or local tax law provisions.
The information contained in this message may be privileged and confidential and protected from
disclosure. If the reader of this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient, you are hereby notified that any
dissemination, distribution or copying of this communication is strictly prohibited. If you have received
this communication in error, please notify us immediately by replying to the message and deleting it
from your computer.
Notice required by law: This e-mail may constitute an advertisement or solicitation under U.S. law, if its
primary purpose is to advertise or promote a commercial product or service. You may choose not to
receive advertising and promotional messages from Ernst & Young LLP (except for Ernst & Young
Online and the
website, which track e-mail preferences through a separate process) at this e-
mail address by forwarding this message to
. If you do so, the sender of this
message will be notified promptly. Our principal postal address is 5 Times Square, New York, NY
10036. Thank you. Ernst & Young LLP
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within
the meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to
inform you that you cannot rely upon any tax advice contained in this communication for the purpose of
avoiding United States federal tax penalties. In addition, any tax advice contained in this communication may
not be used to promote, market or recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-
mail, and delete the original message.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within
the meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to
inform you that you cannot rely upon any tax advice contained in this communication for the purpose of
EFTA01135548
avoiding United States federal tax penalties. In addition, any tax advice contained in this communication may
not be used to promote, market or recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-
mail, and delete the original message.
Any U.S. tax advice contained in the body of this e-mail was not intended or written to be used,
and cannot be used, by the recipient for the purpose of avoiding penalties that may be imposed
under the Internal Revenue Code or applicable state or local tax law provisions.
The information contained in this message may be privileged and confidential and protected from
disclosure. If the reader of this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient, you are hereby notified that any
dissemination, distribution or copying of this communication is strictly prohibited. If you have received
this communication in error, please notify us immediately by replying to the message and deleting it
from your computer.
Notice required by law: This e-mail may constitute an advertisement or solicitation under U.S. law, if its
primary purpose is to advertise or promote a commercial product or service. You may choose not to
receive advertising and promotional messages from Ernst & Young LLP (except for Ernst & Young
Online and the
website, which track e-mail preferences through a separate process) at this e-
mail address by forwarding this message to
. If you do so, the sender of this
message will be notified promptly. Our principal postal address is 5 Times Square, New York, NY
10036. Thank you. Ernst & Young LLP
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered
opinion, within the meaning of Circular 230 issued by the United States Secretary of the Treasury.
Thus, we are required to inform you that you cannot rely upon any tax advice contained in this
communication for the purpose of avoiding United States federal tax penalties. In addition, any tax
advice contained in this communication may not be used to promote, market or recommend a transaction
to another party.
The information contained in this e-mail message is intended only for the personal and confidential
use of the recipient(s) named above. If you have received this communication in error, please notify
us immediately by e-mail, and delete the original message.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA01135549
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.